Accelerating MAPK1 Inhibitor Discovery Through Stacking Ensemble Learning with Graph Neural Networks
Year: 2026
Type: article
Abstract: Mitogen-activated protein kinase 1 (MAPK1) plays a central role in cancer cell proliferation and survival. In this study, we developed an ensemble graph neural network framework integrating graph convolutional neural networks, graph message-passing neural networks, and attention-based graph neural networks to predict MAPK1 inhibitory activity using large-scale quantitative high-throughput screening data. Our models achieved recall ranging from 79.5% to 92.3%, areas under the precision–recall curve ranging from 80.4% to 90.3%, and Matthews correlation coefficients ranging from 0.523 to 0.725 on the independent test set, demonstrating a strong ability to identify MAPK1 inhibitors. The Y-randomization test further confirmed a true relationship between molecular graph structure and MAPK1 inhibitory activity. We also defined the model’s applicability domain to establish clear boundaries for confident prediction. To experimentally validate this approach, we evaluated the approved MAPK1 inhibitor ulixertinib and tested multiple FDA-approved kinase inhibitors, which underscored the model’s predictive ability in the drug development pipeline. Furthermore, we applied the developed models to predict and experimentally validate natural products as potential novel MAPK1 inhibitors. Finally, we developed a web server to deploy this model, enabling rapid and cost-effective identification of MAPK1 inhibitors for hit screening experiments prior to substantial in vitro testing.
Institution: Khon Kaen University
Language: English
Subfield: Drug Discovery
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,499
OpenAlex ID: W7225876951
